Two Sigma Investments’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.55M | Sell |
238,888
-106,919
| -31% | -$3.38M | 0.01% | 961 |
|
2025
Q1 | $11.5M | Buy |
345,807
+70,213
| +25% | +$2.33M | 0.02% | 686 |
|
2024
Q4 | $9.48M | Buy |
275,594
+132,595
| +93% | +$4.56M | 0.02% | 734 |
|
2024
Q3 | $5.72M | Buy |
142,999
+49,640
| +53% | +$1.99M | 0.01% | 975 |
|
2024
Q2 | $2.82M | Buy |
93,359
+22,876
| +32% | +$690K | 0.01% | 1264 |
|
2024
Q1 | $2.37M | Buy |
70,483
+60,479
| +605% | +$2.03M | 0.01% | 1306 |
|
2023
Q4 | $323K | Sell |
10,004
-114,837
| -92% | -$3.71M | ﹤0.01% | 2583 |
|
2023
Q3 | $4.09M | Sell |
124,841
-233,252
| -65% | -$7.64M | 0.01% | 947 |
|
2023
Q2 | $12.6M | Buy |
358,093
+129,170
| +56% | +$4.55M | 0.03% | 513 |
|
2023
Q1 | $7.47M | Buy |
228,923
+45,577
| +25% | +$1.49M | 0.02% | 679 |
|
2022
Q4 | $10.1M | Buy |
183,346
+46,509
| +34% | +$2.56M | 0.03% | 526 |
|
2022
Q3 | $6.06M | Buy |
136,837
+101,837
| +291% | +$4.51M | 0.02% | 659 |
|
2022
Q2 | $1.71M | Sell |
35,000
-193,000
| -85% | -$9.41M | 0.01% | 1228 |
|
2022
Q1 | $11.1M | Buy |
228,000
+216,491
| +1,881% | +$10.5M | 0.03% | 562 |
|
2021
Q4 | $491K | Buy |
+11,509
| New | +$491K | ﹤0.01% | 1993 |
|
2021
Q1 | – | Sell |
-7,888
| Closed | -$285K | – | 2483 |
|
2020
Q4 | $285K | Buy |
+7,888
| New | +$285K | ﹤0.01% | 1745 |
|